Product Information
NITROFURANTOIN MCR 50 MG CAP is a generic product labeled by Zydus Pharmaceuticals (USA) Inc., priced at $0.1650 per EA under NDC 68382055901. Its NADAC has been published 408 times since Dec 12, 2018.
FDA first approved this application on Dec 12, 2017. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
50 mg/1
Manufacturer
Zydus Pharmaceuticals (USA) Inc.NDC
68382055901
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
NITROFURANTOINApproval Type
Generic (ANDA)
FDA Application
ANDA205005FDA Approved
12/12/2017
TE Code
AB
On Market Since
2/15/2018
Pharmacological Classes
Price Statistics
The NADAC for NITROFURANTOIN MCR 50 MG CAP has been published 408 times since Dec 12, 2018, and over the history we have for it it has declined 67.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1650 per EA |
|---|---|
| All-time high | $0.5496 (Feb 10, 2021) |
| All-time low | $0.1396 (May 20, 2026) |
| 52-week high | $0.1866 |
| 52-week low | $0.1396 |
| Median price | $0.3594 |
| Average price | $0.3493 |
| Largest weekly change | +36.3% (Aug 21, 2024) |
| Weeks tracked | 408 |
| Tracking since | Dec 12, 2018 |
Generic Alternatives
The matcher finds 5 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Zydus Pharmaceuticals (USA) Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
nitrofurantoin macrocrystals market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Nitrofuran Antibacterial class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of NITROFURANTOIN MCR 50 MG CAP?
The current National Average Drug Acquisition Cost (NADAC) for NITROFURANTOIN MCR 50 MG CAP, manufactured by Zydus Pharmaceuticals (USA) Inc., is $0.1650 per EA (NDC 68382055901), effective Sep 30, 2026.
How has the price of NITROFURANTOIN MCR 50 MG CAP changed over time?
Over the history we have for it, the NADAC for NITROFURANTOIN MCR 50 MG CAP has declined 67.9%. It has been tracked across 408 weekly CMS publications since Dec 12, 2018.
What are the highest and lowest recorded NADAC prices for NITROFURANTOIN MCR 50 MG CAP?
Since Dec 12, 2018, the NADAC for NITROFURANTOIN MCR 50 MG CAP has ranged from a low of $0.1396 (May 20, 2026) to a high of $0.5496 (Feb 10, 2021), with a median of $0.3594 per EA.
Are there cheaper alternatives to NITROFURANTOIN MCR 50 MG CAP?
5 manufacturers publish a NADAC-priced product with the same active ingredient and strength as NITROFURANTOIN MCR 50 MG CAP in a comparable dosage form, but none are currently priced below it.
Who manufactures NITROFURANTOIN MCR 50 MG CAP?
NITROFURANTOIN MCR 50 MG CAP (NDC 68382055901) is labeled by Zydus Pharmaceuticals (USA) Inc., and CMS classifies it as a generic product.